rs143313706
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_016356.5(DCDC2):c.1044C>T(p.Asp348Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00313 in 1,612,918 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0029 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0032 ( 29 hom. )
Consequence
DCDC2
NM_016356.5 synonymous
NM_016356.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.237
Genes affected
DCDC2 (HGNC:18141): (doublecortin domain containing 2) This gene encodes a doublecortin domain-containing family member. The doublecortin domain has been demonstrated to bind tubulin and enhance microtubule polymerization. This family member is thought to function in neuronal migration where it may affect the signaling of primary cilia. Mutations in this gene have been associated with reading disability (RD) type 2, also referred to as developmental dyslexia. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 6-24178612-G-A is Benign according to our data. Variant chr6-24178612-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 466321.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-24178612-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.237 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0029 (441/152016) while in subpopulation AMR AF= 0.00399 (61/15270). AF 95% confidence interval is 0.00319. There are 4 homozygotes in gnomad4. There are 220 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DCDC2 | NM_016356.5 | c.1044C>T | p.Asp348Asp | synonymous_variant | 9/10 | ENST00000378454.8 | NP_057440.2 | |
DCDC2 | NM_001195610.2 | c.1044C>T | p.Asp348Asp | synonymous_variant | 10/11 | NP_001182539.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCDC2 | ENST00000378454.8 | c.1044C>T | p.Asp348Asp | synonymous_variant | 9/10 | 1 | NM_016356.5 | ENSP00000367715.3 | ||
DCDC2 | ENST00000378450.6 | c.303C>T | p.Asp101Asp | synonymous_variant | 2/3 | 1 | ENSP00000367711.3 |
Frequencies
GnomAD3 genomes AF: 0.00290 AC: 441AN: 151898Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
441
AN:
151898
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00391 AC: 980AN: 250470Hom.: 7 AF XY: 0.00414 AC XY: 560AN XY: 135386
GnomAD3 exomes
AF:
AC:
980
AN:
250470
Hom.:
AF XY:
AC XY:
560
AN XY:
135386
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00315 AC: 4603AN: 1460902Hom.: 29 Cov.: 32 AF XY: 0.00329 AC XY: 2390AN XY: 726752
GnomAD4 exome
AF:
AC:
4603
AN:
1460902
Hom.:
Cov.:
32
AF XY:
AC XY:
2390
AN XY:
726752
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00290 AC: 441AN: 152016Hom.: 4 Cov.: 32 AF XY: 0.00296 AC XY: 220AN XY: 74266
GnomAD4 genome
AF:
AC:
441
AN:
152016
Hom.:
Cov.:
32
AF XY:
AC XY:
220
AN XY:
74266
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | DCDC2: BP4, BP7, BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 09, 2018 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 24, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 01, 2017 | - - |
Autosomal recessive nonsyndromic hearing loss 66;C4479344:Isolated neonatal sclerosing cholangitis Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Autosomal recessive nonsyndromic hearing loss 66;C4015542:Nephronophthisis 19;C4479344:Isolated neonatal sclerosing cholangitis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 02, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at